According to the previous studies of Denkert et al. published in 2010 and 2019 [11,40], pre-NAT TILs are predictive of response to chemotherapy in all IBC subtypes, especially in TN and HER2+ tumours. This evidence concerns the gene ERBB2 and neoplasm.